DE3854205T2 - Zwischenprodukte der Mureidomycin-Gruppe, ihre Herstellung und Verwendung. - Google Patents

Zwischenprodukte der Mureidomycin-Gruppe, ihre Herstellung und Verwendung.

Info

Publication number
DE3854205T2
DE3854205T2 DE3854205T DE3854205T DE3854205T2 DE 3854205 T2 DE3854205 T2 DE 3854205T2 DE 3854205 T DE3854205 T DE 3854205T DE 3854205 T DE3854205 T DE 3854205T DE 3854205 T2 DE3854205 T2 DE 3854205T2
Authority
DE
Germany
Prior art keywords
group
carbon atoms
mureidomycin
compound
tetrahydroisoquinolin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3854205T
Other languages
English (en)
Other versions
DE3854205D1 (de
Inventor
Tatsuo Haneishi
Masatoshi Inukai
Keiko Shimizu
Fujio Isono
Yoshiharu Sakaida
Takeshi Kinoshita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Application granted granted Critical
Publication of DE3854205D1 publication Critical patent/DE3854205D1/de
Publication of DE3854205T2 publication Critical patent/DE3854205T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0217—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -C(=O)-C-N-C(=O)-N-C-C(=O)-
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE3854205T 1987-11-20 1988-11-16 Zwischenprodukte der Mureidomycin-Gruppe, ihre Herstellung und Verwendung. Expired - Fee Related DE3854205T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29335287 1987-11-20
JP29335387 1987-11-20

Publications (2)

Publication Number Publication Date
DE3854205D1 DE3854205D1 (de) 1995-08-24
DE3854205T2 true DE3854205T2 (de) 1996-04-04

Family

ID=26559375

Family Applications (2)

Application Number Title Priority Date Filing Date
DE3854205T Expired - Fee Related DE3854205T2 (de) 1987-11-20 1988-11-16 Zwischenprodukte der Mureidomycin-Gruppe, ihre Herstellung und Verwendung.
DE88310822T Expired - Fee Related DE3880092T2 (de) 1987-11-20 1988-11-16 Antibiotika der Mureidomycin-Gruppe, deren Herstellung und deren Verwendung.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE88310822T Expired - Fee Related DE3880092T2 (de) 1987-11-20 1988-11-16 Antibiotika der Mureidomycin-Gruppe, deren Herstellung und deren Verwendung.

Country Status (8)

Country Link
US (1) US5041423A (de)
EP (2) EP0317292B1 (de)
KR (2) KR0137779B1 (de)
AT (1) ATE125256T1 (de)
CA (1) CA1339595C (de)
DE (2) DE3854205T2 (de)
ES (2) ES2077345T3 (de)
HK (2) HK1003573A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0487756A1 (de) * 1990-11-26 1992-06-03 Hoechst Aktiengesellschaft Antibiotika-Napsamycin A-D, deren Herstellung und pharmazeutische Verwendung
US6228842B1 (en) 1998-11-06 2001-05-08 Microcide Pharmaceuticals, Inc. Pacidamycins produced by Streptomyces coeruleorubidus
US6482921B1 (en) * 1999-01-28 2002-11-19 Essential Therapeutics, Inc. Uridyl peptide antibiotic (UPA) derivatives, their synthesis and use
HU225432B1 (hu) * 2001-09-27 2006-11-28 Biocon Ltd Eljárás pravasztatin nátriumsó elõállítására streptomyces flavidovirens DSM 14455 törzs alkalmazásával
KR102302414B1 (ko) 2014-06-20 2021-09-16 주식회사 만도 임피던스 저감을 위한 피씨비와 섀시간의 그라운드 결합구조

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3341571A1 (de) * 1983-11-17 1985-05-30 Bayer Ag, 5090 Leverkusen Neue antibiotika, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel und zwischenprodukte zu ihrer herstellung
GB8421279D0 (en) * 1984-08-22 1984-09-26 Baldwin J E Antibiotics
IT1184164B (it) * 1985-03-19 1987-10-22 Eniricerche Spa Triptidi ad azione ipotensiva e procedimento per la loro sintesi
DE3787765T2 (de) * 1986-05-20 1994-05-05 Sankyo Co Antibiotika "Mureidomycine A,B,C und D" genannt, deren Verfahren zur Herstellung und deren Verwendung.

Also Published As

Publication number Publication date
EP0517345A1 (de) 1992-12-09
ES2077345T3 (es) 1995-11-16
HK1003573A1 (en) 1998-10-30
KR0137779B1 (ko) 1998-05-15
DE3880092D1 (de) 1993-05-13
ATE125256T1 (de) 1995-08-15
EP0517345B1 (de) 1995-07-19
DE3854205D1 (de) 1995-08-24
EP0317292B1 (de) 1993-04-07
ES2054829T3 (es) 1994-08-16
DE3880092T2 (de) 1993-11-25
KR890008130A (ko) 1989-07-08
EP0317292A2 (de) 1989-05-24
CA1339595C (en) 1997-12-23
US5041423A (en) 1991-08-20
HK1005736A1 (en) 1999-01-22
EP0317292A3 (en) 1990-07-25
KR0137675B1 (ko) 1998-05-15

Similar Documents

Publication Publication Date Title
DE3881246T2 (de) Durch Benzhydryl N-substituierte heterocyclische Derivate, ihre Herstellung und ihre Verwendung.
DK0615549T3 (da) Fremgangsmåde til fremstilling af farmaceutisk aktive thiazolidin- eller oxazolidinforbindelser med en gærreduktase
ATE161848T1 (de) Glycyrrheticsäurederivate
AU3381389A (en) Derivative of caffeic acid and pharmaceutical composition containing the same
FI911016A0 (fi) Menetelmä farmakologisesti aktiivisten substituoitujen -diketonien valmistamiseksi
DE3854205D1 (de) Zwischenprodukte der Mureidomycin-Gruppe, ihre Herstellung und Verwendung.
CA1246583A (en) 4-ISOXAZOLYL)-THIAZOLE-2-OXAMIC ACIDS AND THEIR DERIVATIVES
ES2026548T3 (es) Un procedimiento para preparar penemos.
ATE63911T1 (de) 1,3,5-nonatrienderivate, deren herstellung und verwendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee